|

Software Refraction With Mobilerone Versus Retinoscopy

RECRUITINGN/ASponsored by Beijing Airdoc Technology Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorBeijing Airdoc Technology Co., Ltd.
Started2023-07-15
Est. completion2025-12-30
Eligibility
Age10 Years – 46 Years
Healthy vol.Accepted

Summary

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

Eligibility

Age: 10 Years – 46 YearsHealthy volunteers accepted
Inclusion Criteria:

* • subject with ametropia on each eye ≤-12.00D

  * subject with best corrected visual acuity ≥ 20/25, no amblyopia
  * subject with normal transparency of eyes
  * subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
  * subject able to cooperate with the screen and the operator
  * subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
  * non-diabetic subject
  * non nystagmus subject
  * non-strabismus subject
  * subject who has not had eye surgery less than 1 year old

Exclusion Criteria:

* • subject with a topography showing an anomaly (keratoconus type or other)

  * subject with hyperopia or presbyopia
  * subject with mild myopia ≥ -1.00D
  * subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists

Conditions4

AstigmatismCancerMyopiaMyopia, Moderate

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.